期刊文献+

Risk factors of haemorrhagic transformation for acute ischaemic stroke in Chinese patients receiving intravenous recombinant tissue plasminogen activator:a systematic review and meta-analysis 被引量:20

原文传递
导出
摘要 Objective To identify risk factors for haemorrhagic transformation in Chinese patients with acute ischaemic stroke treated with recombinant tissue plasminogen activator.Methods We searched electronic databases including PubMed,EMBASE,CNKI and WanFang Data for studies reporting risk factors of haemorrhagic transformation after intravenous thrombolysis.Pooled OR,weighted mean difference(WMD)and 95%CI were estimated.Meta-analysis was performed by using Stata V.14.0 software.results A total of 14 studies were included.The results indicated that older age(WMD=3.46,95%CI 2.26 to 4.66,I^(2)=47),atrial fibrillation(OR 2.66,95%CI 1.85 to 3.81,I^(2)=28),previous stroke(OR 1.68,95%CI 1.08 to 2.60,I^(2)=14),previous antiplatelet treatment(OR 1.67,95%CI 1.17 to 2.38,I^(2)=0),higher National Institute of Health stroke scale scores(OR 1.10,95%CI 1.05 to 1.15,I^(2)=36),systolic(WMD=4.75,95%CI 2.50 to 7.00,I^(2)=42)or diastolic(WMD=2.67,95%CI 1.08 to 4.26,I^(2)=35)pressure,and serum glucose level(WMD=1.44,95%CI 0.62 to 2.26,I^(2)=66)were associated with increased risk of post-thrombolysis haemorrhagic transformation.Conclusion The current meta-analysis identified eight risk factors for post-thrombolysis haemorrhagic transformation in Chinese patients with acute ischaemic stroke.Given the risk of bias,these results should be explained with caution and do not justify withholding intravenous thrombolysis.
出处 《Stroke & Vascular Neurology》 SCIE 2018年第4期203-208,共6页 卒中与血管神经病学(英文)
基金 This work was supported by the National Natural Science Foundation of China(grant no.81571153).
  • 相关文献

参考文献6

二级参考文献47

  • 1中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中国医学前沿杂志(电子版),2010,2(4):50-59. 被引量:1830
  • 2王伊龙.临床应用重组组织型纤溶酶原激活剂静脉溶栓治疗缺血性卒中专家共识[J].中华内科杂志,2006,45(7):613-614. 被引量:52
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33004
  • 4Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment : pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials [ J ]. Lancet,2004,363:768 - 774.
  • 5Hacke W, Kaste M, Fieschi C,et al. Randomised double-blind place- bo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemie stroke( ECASS II). Second European-Australasian A- cute Stroke Study Investigators[J]. Laneet,1998,352:1245 -1251.
  • 6Hacke W,Kaste M,Bluhmki E,et al. ECASS investigators. Throm- bolysis with Alteplase 3 to 4.5 hours after acute ischemic stroke[ J]. N Engl Med,2008,359:1317 - 1329.
  • 7Albers GW, Bate VE, Clark WE, et al. Intravenous tissue-type plas- minogen activator for treatment of acute stroke : the standard treatment with alteplase to reverse stroke ( STARS ) study [ J ]. JAMA, 2000, 283,1145 - 1150.
  • 8Katzan IL,Furlan AJ,Lloyd LE,et al. Use of tissue-type plasminogen activator for acute ischemic stroke:the Cleveland area experience[ J]. JAMA ,2000,288:1151 - 1158.
  • 9Nakano S, Iseda T, Kawano H, et al. Parenchymal hyperdensity on computed tomography after intra-arterial reperfusion theraphy for acute middle cerebral artery occlusion:incidence and clinical significance [ J ]. Stroke, 2001,32 ( 9 ) : 2042 - 2048.
  • 10Molina C,Montaner J,Abilleira S, et al. Timing of spontaneous reca- nalization and risk of hemorrhagic trans-formation in acute cardioem- bolic stroke[ J]. Stroke,2001,32 : 1079 - 1084.

共引文献124

同被引文献100

引证文献20

二级引证文献131

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部